Effect of the anti‐estrogen, nafoxidine, on nzb/w autoimmune disease
Open Access
- 1 May 1978
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 21 (4), 414-417
- https://doi.org/10.1002/art.1780210403
Abstract
Treatment of female NZB/W F1 mice with Nafoxidine, an anti-estrogen, led to delayed manifestation of autoimmune features. Such treated mice had reduced anti-DNA antibodies, reduced proteinuria, and improved survival. These results support the hypothesis that sex hormones play an important role in the expression of autoimmunity and suggest that estrogens may accelerate autoimmunity in NZB/W F1 mice.Keywords
This publication has 13 references indexed in Scilit:
- Androgenic Hormones Modulate Autoantibody Responses and Improve Survival in Murine LupusJCI Insight, 1977
- Ribavirin: Efficacy in the Treatment of Murine Autoimmune DiseaseScience, 1977
- Androgens on the estrogen receptor II — correlation between nuclear translocation and uterine protein synthesisSteroids, 1977
- Sex differences in formation of anti-T-cell antibodiesNature, 1976
- In vivo effect of anti-estrogens on the localisation and replenishment of estrogen receptorMolecular and Cellular Endocrinology, 1975
- Androgen-induced nuclear accumulation of the estrogen receptorSteroids, 1975
- Therapeutic studies in NZB/W MICEArthritis & Rheumatism, 1975
- Oestrogen receptors and antagonism of steroid hormone actionNature, 1974
- The Pathogenesis of Autoimmunity in New Zealand Black MiceModern Aspects of Electrochemistry, 1974
- Estrogen receptor · anti-estrogen complex: Atypical binding by uterine nuclei and effects on uterine growthSteroids, 1973